Frontlight ResearchEarly access
Trial site
Columbia University Iriving School of Medicine
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)2 trials
- Hepatitis B2 trials
- Hepatitis C2 trials
- Liver cirrhosis2 trials
- Phase
- Phase 21 trial
- Status
- Active, not recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1 trial
- Northwestern University1 trial
Running trials
Recruiting
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)1 recruiting
- Hepatitis B1 recruiting
- Hepatitis C1 recruiting
- Liver cirrhosis1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026